[
    [
        {
            "time": "2020-10-01",
            "original_text": "After Hours Most Active for Oct 1, 2020: VICI, AAPL, SLB, ABBV, SGMS, MSFT, HST, MNST, APA, RUN, GE, VZ",
            "features": {
                "keywords": [
                    "Most Active",
                    "VICI",
                    "AAPL",
                    "ABBV",
                    "MSFT"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "healthcare",
                    "energy"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "After Hours Most Active for Oct 1, 2020: VICI, AAPL, SLB, ABBV, SGMS, MSFT, HST, MNST, APA, RUN, GE, VZ",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2020-10-01",
            "original_text": "Best ETFs for 2020: The AdvisorShares Vice ETF Saved by SAM and TMO",
            "features": {
                "keywords": [
                    "ETFs",
                    "AdvisorShares",
                    "Vice",
                    "SAM",
                    "TMO"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "financial products"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Best ETFs for 2020: The AdvisorShares Vice ETF Saved by SAM and TMO",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2020-10-01",
            "original_text": "Stocks Are Expensive. These 14 Are Cheap and Could Grow.",
            "features": {
                "keywords": [
                    "Expensive",
                    "Cheap",
                    "Grow"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Stocks Are Expensive. These 14 Are Cheap and Could Grow.",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-10-01",
            "original_text": "Cramer Gives His Opinion On AbbVie, Snowflake And More",
            "features": {
                "keywords": [
                    "Cramer",
                    "Opinion",
                    "AbbVie",
                    "Snowflake"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Cramer Gives His Opinion On AbbVie, Snowflake And More",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-10-01",
            "original_text": "7 Dividend Stocks Perfect for a Retiree’s Portfolio",
            "features": {
                "keywords": [
                    "Dividend",
                    "Stocks",
                    "Retiree",
                    "Portfolio"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "income stocks"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "7 Dividend Stocks Perfect for a Retiree’s Portfolio",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-10-01",
            "original_text": "AbbVie: New Brunswick, British Columbia List SKYRIZI On Its Provincial Formulary",
            "features": {
                "keywords": [
                    "AbbVie",
                    "SKYRIZI",
                    "Provincial Formulary"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AbbVie: New Brunswick, British Columbia List SKYRIZI On Its Provincial Formulary",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]